Literature DB >> 12925422

Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.

S Jo-Anne Wilson1, Philip S Wells, Michael J Kovacs, Geoffrey M Lewis, Janet Martin, Erica Burton, David R Anderson.   

Abstract

BACKGROUND: There is growing evidence that better outcomes are achieved when anticoagulation is managed by anticoagulation clinics rather than by family physicians. We carried out a randomized controlled trial to evaluate these 2 models of anticoagulant care.
METHODS: We randomly allocated patients who were expected to require warfarin sodium for 3 months either to anticoagulation clinics located in 3 Canadian tertiary hospitals or to their family physician practices. We evaluated the quality of oral anticoagulant management by comparing the proportion of time that the international normalized ratio (INR) of patients receiving warfarin sodium was within the target therapeutic range +/- 0.2 INR units (expanded therapeutic range) while they were managed in anticoagulation clinics as opposed to family physicians' care over 3 months. We measured the rates of thromboembolic and major hemorrhagic events and patient satisfaction in the 2 groups.
RESULTS: Of the 221 patients enrolled, 112 were randomly assigned to anticoagulation clinics and 109 to family physicians. The INR values of patients who were managed by anticoagulation clinics were within the expanded therapeutic range 82% of the time versus 76% of the time for those managed by family physicians (p = 0.034). High-risk INR values (defined as being < 1.5 or > 5.0) were more commonly observed in patients managed by family physicians (40%) than in patients managed by anticoagulation clinics (30%, p = 0.005). More INR measurements were performed by family physicians than by anticoagulation clinics (13 v. 11, p = 0.001). Major bleeding events (2 [2%] v. 1 [1%]), thromboembolic events (1 [1%] v. 2 [2%]) and deaths (5 [4%] v. 6 [6%]) occurred at a similar frequency in the anticoagulation clinic and family physician groups respectively. Of the 170 (77%) patients who completed the patient satisfaction questionnaire, more were satisfied when their anticoagulant management was managed through anticoagulation clinics than by their family physicians (p = 0.001).
INTERPRETATION: Anticoagulation clinics provided better oral anticoagulant management than family physicians, but the differences were relatively modest.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925422      PMCID: PMC180652     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  41 in total

Review 1.  Managing oral anticoagulant therapy.

Authors:  J Ansell; J Hirsh; J Dalen; H Bussey; D Anderson; L Poller; A Jacobson; D Deykin; D Matchar
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; G Agnelli; R D Hull; T A Morris; M Samama; V Tapson; J G Weg
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 3.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 4.  Antithrombotic agents in coronary artery disease.

Authors:  J A Cairns; P Théroux; H D Lewis; M Ezekowitz; T W Meade
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 5.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 6.  Antithrombotic and thrombolytic therapy for ischemic stroke.

Authors:  G W Albers; P Amarenco; J D Easton; R L Sacco; P Teal
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 7.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

Authors:  P D Stein; J S Alpert; H I Bussey; J E Dalen; A G Turpie
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

8.  Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community.

Authors:  J Holden; K Holden
Journal:  J Clin Pharm Ther       Date:  2000-02       Impact factor: 2.512

9.  Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic.

Authors:  M A Chamberlain; N A Sageser; D Ruiz
Journal:  J Am Board Fam Pract       Date:  2001 Jan-Feb

10.  Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio.

Authors:  J C Forfar
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

View more
  53 in total

1.  Anticoagulation.

Authors:  David Massel
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

2.  Anticoagulation.

Authors:  Patrick J Potter
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

3.  Anticoagulation.

Authors:  Garey Mazowita
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

4.  Anticoagulation.

Authors:  David A Fitzmaurice
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

Review 5.  Home versus in-patient treatment for deep vein thrombosis.

Authors:  Richard Othieno; Emmanuel Okpo; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2018-01-09

6.  [Quality of life of patients treated with oral anticoagulants].

Authors:  M Yanes Baonza; A Cabrera Majada; J M Ferrer García-Borrás; R Sánchez González
Journal:  Aten Primaria       Date:  2005-09-15       Impact factor: 1.137

Review 7.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 8.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 9.  Impact on patient care: patient case through the continuum of care.

Authors:  Scott Kaatz
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

Review 10.  Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.

Authors:  Thomas P Moyer; Dennis J O'Kane; Linnea M Baudhuin; Carmen L Wiley; Alexandre Fortini; Pamela K Fisher; Denise M Dupras; Rajeev Chaudhry; Prabin Thapa; Alan R Zinsmeister; John A Heit
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.